Transfusion Strategies in Patients with Mitral Valve Replacement

  • B. M. Gumeniuk National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0002-7954-4769
  • I. P. Golota National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.30702/ujcvs/21.4306/g032042-048/126.42-08
Keywords: donor blood, acquired mitral valve disease, blood-saving technology, artificial circulation, bloodless transfusion strategies, transfusiology, anesthesiology

Abstract

The aim. To carry out research of liberal, restrictive and blood-saving transfusion strategies in patients with mitral valve replacement (MVR) in the conditions of artificial blood circulation during operation, in intensive care unit, and in the postoperative period.

Material and methods. Retrograde examinations were performed in 70 patients who underwent surgery for ac-quired mitral valve disease. Our research consisted of three stages: stage 1 involved the study of the volume of transfu-sions of donor blood components during MVR, stage 2 involved the study of the volume of transfusion of donor blood components in the emergency room, stage 3 involved the study of the volume of transfusions of donor blood components in the intensive care unit. All the patients were divided into 3 groups. Group A included 14 patients in whom (arbitrary) liberal transfusion strategy (LTS) with transfusion of donor blood components was applied during the operation. Group B included 19 patients in whom (economical) restrictive transfusion strategy (RTS) during surgery with transfusion of donor blood components was applied. Group C included 37 patients in whom the patient’s autologous blood-saving tech-nology (BST) was applied during the operation.

Results and discussion. At stage 1 of the study, the volume of packed RBCs per 1 transfusion in group A exceeded the volume of packed RBCs per 1 transfusion in group B by 68.0%. The volume of transfusions of native fresh-frozen plasma (FFP) in group A exceeded that in group B by 73.5%. The volume of platelet transfusions (PT) in group A at stage 1 was 75.0%. At stage 2 of the study, the total volume of PT in patients of group A was still 3.0 times higher and FFP was 2.7 times higher than that in group B. At this stage of the study, there was also a 2.6-fold decrease in the volume of PT per 1 transfusion in group B compared with group A. In total, during 3 stages of the study, the volume of PT use in group A was 5.7 times higher, and in group B it was 3.9 times higher than that in group C. The volume of FFP use in group A was 4.4 times higher, and in group B it was 3.8 times higher than that in group C.

Conclusions. The use of LTS in group A and RTS in group B resulted in 5.2-fold and 3.8-fold increase in the total volume of transfused donor blood components, repsectively, compared to group C.

References

  1. Schwann TA, Engoren M, Engelman D. Perioperative Blood Transfusions Are Not Benign. Ann Thorac Surg. 2020 Aug; 110(2):749. https://doi.org/10.1016/j.athoracsur.2019.10.092.
  2. Oz BS, Arslan G, Kaya E, Gunay C, Cingoz F, Arslan M. Comparison of results of autologous versus homologous blood transfusion in open-heart surgery. Cardiovasc J Afr. 2013 May; 24(4):121-123, 129. https://doi.org/10.5830/CVJA-2013-020.
  3. Shaw RE, Johnson CK, Ferrari G, Zapolanski A, Brizzio M, Rioux N, Edara S, Sperling J, Grau JB. Balancing the benefits and risks of blood transfusions in patients undergoing cardiac surgery: a propensity-matched analysis. Interact Cardiovasc Thorac Surg. 2013 Jul; 17(1):96-102. https://doi.org/10.1093/icvts/ivt124.
  4. Zimmermann E, Zhu R, Ogami T, Lamonica A, Petrie JA 3rd, Mack C, Lang S, Avgerinos DV. Intraoperative Autologous Blood Donation Leads to Fewer Transfusions in Cardiac Surgery. Ann Thorac Surg. 2019 Dec;108(6):1738-1744. https://doi.org/10.1016/j.athoracsur.2019.06.091.
  5. Henderson RA, Mazzeffi MA, Strauss ER, Williams B, Wipfli C, Dawood M, Taylor BS, Tanaka KA. Impact of intraoperative high-volume autologous blood collection on allogeneic transfusion during and after cardiac surgery: a propensity score matched analysis. Transfusion. 2019 Jun; 59(6):2023-2029. https://doi.org/10.1111/trf.15253.
  6. Barile L, Fominskiy E, Di Tomasso N, Alpìzar Castro LE, Landoni G, De Luca M, Bignami E, Sala A, Zangrillo A, Monaco F. Acute Normovolemic Hemodilution Reduces Allogeneic Red Blood Cell Transfusion in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Trials. Anesth Analg. 2017 Mar; 124(3):743-752. https://doi.org/10.1213/ANE.0000000000001609.
  7. Goldberg J, Paugh TA, Dickinson TA, Fuller J, Paone G, Theurer PF, Shann KG, Sundt TM 3rd, Prager RL, Likosky DS; PERForm Registry and the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. Greater Volume of Acute Normovolemic Hemodilution May Aid in Reducing Blood Transfusions After Cardiac Surgery. Ann Thorac Surg. 2015 Nov; 100(5):1581-1587; discussion 1587. https://doi.org/10.1016/j.athoracsur.2015.04.135.
  8. George TJ, Beaty CA, Kilic A, Haggerty KA, Frank SM, Savage WJ, Whitman GJ. Hemoglobin drift after cardiac surgery. Ann Thorac Surg. 2012 Sep; 94(3):703-709. https://doi.org/10.1016/j.athoracsur.2012.03.038.
  9. Qian L, Zheng J, Chen L, Jiang J, Chen Y, Shi L, Zhao H, Ni Y. Intraoperative autologous based blood conservation strategies in mitral valve replacement. Zhonghua Wai Ke Za Zhi. 2016 Feb 1;54 (2):125-128. https://doi.org/10.3760/cma.j.issn.0529-5815.2016.02.010.
  10. Lazoryshynets VV, Popov VV, Gurtovenko OM, Gumeniuk BM, Diachenko VL, Hrypachenko AI, Tikhonenko LI, Pukas KV. [Blood-saving technology in surgical correction of mitral valve diseases using the cardiopulmonary bypass]. Journal of the National Academy of Medical Sciences of Ukraine. 2016;22(1):80-86. Ukrainian.
  11. Ad N, Holmes SD, Patel J, Shuman DJ, Massimiano PS, Choi E, Fitzgerald D, Halpin L, Fornaresio LM. The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery. J Thorac Cardiovasc Surg. 2017 Mar;153(3):597-605.e1. https://doi.org/10.1016/j.jtcvs.2016.10.083.
  12. Mirzaei S, Hershberger PE, DeVon HA. Association Between Adverse Clinical Outcomes After Coronary Artery Bypass Grafting and Perioperative Blood Transfusions. Crit Care Nurse. 2019 Feb;39(1):26-35. https://doi.org/10.4037/ccn2019589.
  13. Schwann TA, Habib JR, Khalifeh JM, Nauffal V, Bonnell M, Clancy C, Engoren MC, Habib RH. Effects of Blood Transfusion on Cause-Specific Late Mortality After Coronary Artery Bypass Grafting-Less Is More. Ann Thorac Surg. 2016 Aug;102(2):465-473. https://doi.org/10.1016/j.athoracsur.2016.05.023.
  14. Wang H, Zheng W, Fang W, Meng G, Zhang L, Zhou Y, Gu E, Liu X. Safety, efficacy, and cost-effectiveness of intraoperative blood salvage in OPCABG with different amount of bleeding: a single-center, retrospective study. J Cardiothorac Surg. 2018 Oct 17;13(1):109. https://doi.org/10.1186/s13019-018-0794-6.
  15. World Health Organization. Global Forum for Blood Safety: Patient Blood Management 14─15 March 2011, Dubai, United Arab Emirates. Geneva: WHO; c2011 [cited 2021 Feb 22]. Available from: https://www.who.int/bloodsafe-ty/events/gfbs_01_pbm/en
Published
2021-06-29
How to Cite
1.
Gumeniuk BM, Golota IP. Transfusion Strategies in Patients with Mitral Valve Replacement. ujcvs [Internet]. 2021Jun.18 [cited 2024Dec.22];(2 (43):42-8. Available from: https://cvs.org.ua/index.php/ujcvs/article/view/417
Issue
Ukrainian Journal of Cardiovascular Surgery No 2 (43) 2021
Section
ACQUIRED HEART DISEASES